PMID- 35764015 OWN - NLM STAT- MEDLINE DCOM- 20220817 LR - 20220817 IS - 1878-1705 (Electronic) IS - 1567-5769 (Linking) VI - 110 DP - 2022 Sep TI - Predictive role of sampling-time specific prognostic nutritional index cut-off values for intravenous immunoglobulin resistance and cardiovascular complications in Kawasaki disease. PG - 108986 LID - S1567-5769(22)00470-2 [pii] LID - 10.1016/j.intimp.2022.108986 [doi] AB - BACKGROUND: Intravenous immunoglobulin (IVIG) resistance and cardiovascular complications prediction are pivotal topic of interests in Kawasaki disease (KD). The prognostic nutritional index (PNI) has been proposed to be valuable in predicting the severity of inflammatory status and prognosis in clinical circumstances, with limited data in KD. Therefore, we prospectively investigated the role of sampling-time specific PNI cut-off values in predicting initial IVIG resistance as well as cardiovascular complications in patients with KD for the first time. METHODS: A total of 755 patients with KD were prospectively recruited between January 2015 and December 2019. Patients with KD were subgrouped based on the presence of IVIG resistance or cardiovascular complications. The clinical and laboratory parameters were compared. Multivariate logistic regression analysis was performed to identify the independent risk factors for IVIG resistance and cardiovascular complications. The receiver operating characteristic (ROC) curve was further applied to assess the predictive values of PNI in IVIG resistance and cardiovascular complications. RESULTS: The lower level of PNI was identified as independent risk factors for initial IVIG resistance and cardiovascular complications. The discriminating cut-off values of the PNI for IVIG resistance, all cardiovascular complications, CALs, KDSS and myocarditis were 47.8, 52.2, 38.6, 48.2 and 52.0, with the corresponding sensitivities of 0.573, 0.679, 0.174, 0.750, 0.851, and specificities of 0.753, 0.549, 0.957, 0.679 and 0.576, respectively. After sampling time stratification, the sensitivities and specificities of the PNI obtained at the sixth day from fever onset for prediction of both IVIG resistance (0.778, 0.787) and all cardiovascular complications (0.667, 0.753) remarkably improved. CONCLUSION: PNI may serve as a promising predictor for KDSS in patients with KD. PNI obtained at sixth day from fever onset possess good predictive power for both IVIG resistance and all cardiovascular complications in KD. CI - Copyright (c) 2022 Elsevier B.V. All rights reserved. FAU - Liu, Xiaoliang AU - Liu X AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Shao, Shuran AU - Shao S AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Zhang, Nanjun AU - Zhang N AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Wu, Mei AU - Wu M AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Liu, Lei AU - Liu L AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Duan, Hongyu AU - Duan H AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Liu, Zhongqiang AU - Liu Z AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Zhou, Kaiyu AU - Zhou K AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Hua, Yimin AU - Hua Y AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. FAU - Wang, Chuan AU - Wang C AD - Department of Pediatric Cardiology, The Cardiac Development and Early Intervention Unit, The Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; The Key Laboratory of Development and Diseases of Women and Children of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; West China Medical School of Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: 805101396@qq.com. LA - eng PT - Journal Article DEP - 20220625 PL - Netherlands TA - Int Immunopharmacol JT - International immunopharmacology JID - 100965259 RN - 0 (Immunoglobulins, Intravenous) SB - IM MH - Fever/drug therapy MH - *Heart Diseases/drug therapy MH - Humans MH - Immunoglobulins, Intravenous/therapeutic use MH - Infant MH - *Mucocutaneous Lymph Node Syndrome/complications/diagnosis/drug therapy MH - Nutrition Assessment MH - Prognosis MH - Retrospective Studies OTO - NOTNLM OT - Cardiovascular complications OT - Intravenous immunoglobulin resistance OT - Kawasaki disease OT - Prognostic nutritional index EDAT- 2022/06/29 06:00 MHDA- 2022/08/18 06:00 CRDT- 2022/06/28 18:25 PHST- 2022/03/30 00:00 [received] PHST- 2022/06/05 00:00 [revised] PHST- 2022/06/17 00:00 [accepted] PHST- 2022/06/29 06:00 [pubmed] PHST- 2022/08/18 06:00 [medline] PHST- 2022/06/28 18:25 [entrez] AID - S1567-5769(22)00470-2 [pii] AID - 10.1016/j.intimp.2022.108986 [doi] PST - ppublish SO - Int Immunopharmacol. 2022 Sep;110:108986. doi: 10.1016/j.intimp.2022.108986. Epub 2022 Jun 25.